Friday, March 28, 2014

Part 10: "In favor/Out of favor" stock strategy



Do you understand what we are doing here?

I was talking to a very good friend about the sale of Penny Marijuana Stocks. As we were discussing the issue, I realized that she had buying and selling of these stocks mixed up with buying and selling of Marijuana. She lives in Pennsylvania and thought that she had to wait until Marijuana became legal in Pennsylvania before buying stock in Marijuana companies.

No, you are a citizen of the United States meaning you can buy stock on the Over-the-Counter Market (OTC) or the organized exchanges in any company that makes any product in any state that you want. So someone in Pennsylvania, Maryland, New York, Delaware, or any other state can buy Marijuana Stocks anytime they feel like it without fear of law enforcement.

Starting your own business

In fact, I suggest since this industry is in its beginning stages, you should borrow $1,000 or more and set up a portfolio of Marijuana Stocks using a "In favor/Out of favor" stock strategy. If you want, your family and friends could form a stock club and invest in only Marijuana Stocks. You may want to focus on one company in the hopes of buying enough stock to influence the management in such areas as employment, the environment, and social activities.


Click on the link above to lean how you, your friends, and family can start your own stock club or business with very little money.

Some of you talk all the time about starting your own business. Well here is a way to get into your own business with very little money. You only risk what money you put into it. Now this is for people who are “doers” not “talkers.” This method of investing is how I got started in the market some 42 years ago and I think that I made out OK.  



 Here is the result of my successful investment life.




Setting up a Portfolio


In this last part of investing in Penny Marijuana Stocks, we will discuss a strategic approach to your speculative investment. If you want to gamble, just pick one or two stocks, buy the stock, and take your chances. If you want a better chance of making money off of these investments then you want to approach this with a strategy. The main point of your Marijuana Penny Stock Strategy is to diversify your portfolio. That is to protect your investments. By diversification, if one or two companies fail, you have three companies that still can make a profit for you.  

When it comes to gambling, it is all or nothing. Usually when you are gambling and you are unlucky, you can’t recover. I prefer high speculation.

Here is an example portfolio for you to learn from.  Let’s say you have $1,000 to work with. You may have borrowed the money or saved up for it. You bought the following stocks;

1. Bought 1,500 shares of Hemp, Inc. (OTC: HEMP) at 20 cents per share, spending $300.00,

2. Bought  222 shares of Greengro technologies Inc. (OTC: GRNH)Description: http://o.aolcdn.com/cdn.webmail.aol.com/38364/images/common/space.gif at 45 cents per share, spending  $99.90,

3. Bought  10,000 shares of Tranzbyt Corporation (OTC: ERBB) at 2 cents per share, spending  $200.00,

4. Bought  40 shares of Endocan Corporation (OTC: ENDO) at  $3.37 per share, spending $134.80,

5. Bought  829 shares of MediSwipe, Inc. (OTC: MWIP) at .32 cent per share, spending $265.30.

I would check each one of these stocks every day. When some good news comes out about a stock, it may double or triple in a day. If that is the case, I would sell at least half of the stock and put the profits into another stock. If good news comes out about the industry and all or most of the stocks go up, doubling or tripling, I would sell half of the stocks and wait until the price comes back down and buy the same stocks again. Make sure that it is 30 days after selling the same stocks so that the IRS does not charge you with “short selling.”  



Above is an example of how I would set up a portfolio of stocks in the industry. This is in no means an endorsement of these stocks by me. 

As I said before, you risk the money that you put into your investment. In my opinion and it is only my opinion that this industry will grow rapidly and the stocks that I talked about over the past 9 parts will be the leaders in this industry. 


Parts 1 Thru 9
  
Parts 1 thru 9 talked about the individual Marijuana Stocks on the Over-the-Counter (OTC) Market. These are the stocks that you may select from when building your Marijuana Portfolio. 

If you are interested, open your brokerage account, send in your money for your account, then purchase your securities. It is that simple.

With any investment, speculation, or gamble, you have risks. I suggest that you take my free online course before you make any investments or speculate.  Here is the link for the course below.



The Greedy Friends Stock Club Stock and Bond Course   


How is my IRA portfolio doing?

After 5 years, is my investment strategy still working?

Going toward the end of the first quarter of the year, my portfolio has increased by 2.377% since January 1, 2014. The Dow has moved down 1.88% in the same time period. I have made 6.88% in interest income on my account since January 1, 2014.

I think that I have moved into retirement in good shape.


I would have to say that I have come a long way since 3 years old.

Sunday, March 23, 2014

Part 9: Endocan Corporation (OTC: ENDO)


Patient Resource Center


Endocan Corporation's Patient Resource Center allows patients to be as open and connected as they wish. The examples presented here are included with the full knowledge and consent of the patient. See the link below.





ENDO recently sold for 15.6 Cents. Its 52 week high was 25 Cents and the low was 1.9 Cents.  As of March 23, 2014 the stock sold for 8.55 Cents a Share.  As of the time the blog was written, no information was published as to the trading of insiders on this stock.


Get the current quote from the link above. 

Endocan Corporation is currently developing new natural products based on innovative formulations to utilize the unique and potent benefits of the cannabis and hemp plants. Medicinal properties of cannabis and hemp have been known and applied for thousands of years. With the aid of scientific research, Endocan Corporation is translating such knowledge into development of effective cannabinoid formulation-based health and wellness solutions as well as cosmeceutical, nutraceutical, and food brands throughout the world. The Company's health and wellness, nutritional, and cosmetics lines will address personal needs and will evolve with the introduction of new formulations and products, advancing the Company within the expanding multibillion-dollar global market.

This document in the link above provides dramatic photographic evidence of cannabis extracts curing basal-cell carcinoma via topical application.
This Australian woman had a number of surgeries to remove basal cell carcinoma lesions. She subsequently successfully treated a new lesion appeared on her right cheek with the topical application of cannabis extracts applied daily until her surgeon stated that there was no need for surgery since the lesion on her cheek was gone.
Endocan develops products for critical ailments.
The number of diagnoses for various life-threatening diseases is rising every day. Endocan recognizes this global pandemic and is committed to with smart and sensible science.

Endocan's product lines continue to mature toward critical care for people suffering from life threatening diseases like cancer and HIV. The Company's strategic research collaborations, including our strategic partners, Cannabis Science, Inc. and the medical cannabis dispensaries in legal state jurisdictions, will advance these cannabinoid-based breakthroughs in the rapidly expanding critical care market. Further, while chemotherapy and surgical treatment costs quickly rise into the hundreds of thousands of dollars per patient on an annual basis, safe, natural, and effective cannabinoid-based treatments for the same ailments are projected to cost less than ten thousand dollars per patient per annum.

Diagnoses of certain maladies are rising, and more diseases are constantly added to the medical canon. Many diseases have been classified as epidemics. The people on this planet are in dire need of something new. Endocan has identified 20 critical ailments that cannabinoids can treat and numerous skin afflictions as well.

This section covers the 5 Why's and 1 How about these ailments:

Who can get them? What are they? When can a patient contract them? Where in the body do they appear, and what are the symptoms? Why do they show up? And lastly: How can cannabinoids make a difference? Explore the company website for this information, whether you are a patient, have a loved one with an illness, or are merely interested in cannabinoid science.
See the company website: www.endocan.com

Table: Market Analysis
Description: http://endocan.com/images/stories/demo/charts/table-market-analysis.jpg



Market Analysis Chart
Description: http://endocan.com/images/stories/demo/charts/market-analysis-pie.jpg


Table:
 Global Potential Customers
Description: http://endocan.com/images/stories/demo/charts/table-global-potential-customers.jpgGlobal Potential Customers Chart
Description: http://endocan.com/images/stories/demo/charts/global-potential-customers-pie.jpg

Table: Global Potential Customers - Cancer
Description: http://endocan.com/images/stories/demo/charts/table-global-potential-customers-cancer.jpgGlobal Potential Customers with Cancer Chart
Description: http://endocan.com/images/stories/demo/charts/global-potential-customers-cancer.jpg
Forward Looking Statements

This Company Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. The Company does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Endocan Corporation
President
Dr. Dorothy Bray
info@endocan.com This email address is being protected from spambots.  You need JavaScript enabled to view it.
www.endocan.com
+1.866.326.5595


What we will do next!

In part 10, we will look at how to create a low cost portfolio of these nine stocks from part 1 thru part 9 for your speculative money making venture. 

You may consider contacting family and friends in the hope of starting a stock club, investing in such stocks. 

If you are the type of person that can think like a leader instead of a commoner, you may think about starting a stock club with the objective of influencing or taking over a corporation. 

Why? To give your family some financial security and power in society.   

Sunday, March 16, 2014

Part 8: MediSwipe, Inc. (OTC: MWIP)



MediSwipe, Inc. (OTC: MWIP) offers a secure and reliable transaction processing and security solutions for the medical and healthcare industries, using internet point-of-sale, e-commerce and mobile terminals. It provides a complete line of merchant services for healthcare sector, including Visa, MasterCard and merchant accounts, debit and credit card transaction processing, and gift/royalty card programs. The company was founded in February 1997 and is headquartered in West Palm Beach, FL. The recent price of the stock is 33 Cents. The recent 52 week high was $1.27 and the low was 8 Cents.  

Click the link above to see insider buy/own/sell action



LOS ANGELES, CA, Oct 28, 2013 (Marketwired via COMTEX) -- MediSwipe Inc. (www.MediSwipe.com ) (otcqb:MWIP), the leader in Compassionate Care Technology Solutions for the medicinal marijuana industry, today announced that the Company's CEO B. Michael Friedman is featured within a video interview at www.CEOroadshow.com . In the interview, Mr. Friedman discusses MediSwipe's history, evaluates the Company's current situation, defines MWIP's objectives and presents a roadmap to achieve its staged objectives.

The feature video interview may be seen by all investors, shareholders and the general public by visiting www.CEORoadshow.com , and clicking on the MediSwipe Interview.

"I am very pleased to be a guest at CEORoadshow.com, and keep our shareholders and new investors up to date with the help of new media and technology as it relates to the current status and forward progress of our Company," stated B. Michael Friedman, CEO of MediSwipe.

Starter Kits
About MediSwipe Inc.

MediSwipe Inc. ( www.MediSwipe.com ) provides innovative patient solutions and is the leader in Compassionate Care Technology for the medicinal marijuana industry. MediSwipe provides terminal-based service packages and integrated Web Portal add-ons for physicians, clinics, hospitals and medical dispensaries that include: digital patient records, Electronic Referrals, Credit/Debit Card merchant services and health and wellness products including beverages Chillo and C+Swiss.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of MediSwipe Inc. to be materially different from the statements made herein.

CEO RoadShow DISCLAIMER; DISCLOSURE

Disclaimer must be read and fully understood before using this website or any affiliated or related blog, Facebook pages, Twitter page, message boards or joining our e-mail list.

Release of Liability: Through use of this website viewing or using you agree to holdwww.CEORoadShow.com , its operators, owners, and any affiliates, officers, directors, employees or related person(s) harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur.

CEORoadShow.com, www.CEORoadShow.com , their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, "CEO RoadShow") are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. CEORoadShow.com as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by CEO RoadShow.com as defined.

CEO RoadShow.com provides Investor Media, News, Research and IR Services. The IR-Channels, CEO RoadShow Videos, Investor Media, publications or presentations, including web content on CEORoadShow.com are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in CEORoadShow.com, CEO RoadShow interviews, company profiles, or other investor relations media and presentations are subject to change.

CEO RoadShow.com offers digital investor relations and public relations services to paying clients and some of those clients host IR-Channels and forums on CEO RoadShow.com. In the purview of Section 17(b) of the Securities Act of 1933 and in accordance with FTC 16 CFR Part 255, we call the reader's attention to the fact that the CEO RoadShow.com is an entity engaged in the business of public relations and investor relations and has been hired by certain Companies to increase investor awareness to the investor and consumer community. Full financial disclosures for all public company clients featured on CEO RoadShow.com are available on this website through the following link: Disclosures.

Stock market investing is inherently risky. CEO RoadShow.com is not responsible for any gains or losses that result from the opinions expressed on this website, in its CEO RoadShow interviews, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.

We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov .

Colorado stash: $184M in marijuana taxes

Click on the link below 


Saturday, March 8, 2014

Part 7: Tranzbyt Corporation (OTC: ERBB)



The Tranzbyte Corporation (Symbol: ERBB)  now becomes a driving force behind Altitude Organix, OneBodÄ“ Nutraceuticals, The YO! Debit Card, and ProximaRF.  It sold on the OTC Market recently for 2 cents. On Friday March 7, 2014, the stock sold for 3.18 cents, selling at its all-time high.


Tranzbyte Corporation attracts established and early growth businesses seeking to take advantage of resources not generally available to private companies through the public capital markets and provides them mission-critical capital, legal, accounting, and public relations resources. Tranzbyte then acquires these companies and infuses them with the expertise and resources needed to transform them into their own unique, fully-reporting, publicly-traded, bulletin board companies. Following each spin out, Amergence uses its contacts and expertise to assist each company's introduction into the public marketplace.

The primary goal of the new business development enterprise ("BDE") is to coordinate services and activities intended to foster and promote a business environment capable of accelerating the growth of these chosen innovative companies. In exchange for its services, Tranzbyte accepts equity positions in each of these promising new companies which are then divided between Amergence and individual current ERBB shareholders following every spin-out.

David G. Gwyther, Tranzbyte's president says, "We refer to this process as 'dividend farming.' As a result of this process, I believe that dividend farming will induce many of our shareholders to retain and grow their positions in Tranzbyte because doing so will enable them to receive a portion of every company Tranzbyte elects to 'spin out' as each becomes its own fully reporting public company. Through our acquisition of these diverse companies, Tranzbyte Corporation believes it will generate a diverse interest in the Company from many different investment segments."

With management expertise and offices around the globe, Tranzbyte is uniquely positioned to introduce these bold, edgy, or disruptive businesses to the world as each is spun out to become their own individual fully-reporting public companies.

The Tranzbyte Corporation (See website: www.tranzbyte.com) is a driving force behind Altitude Organic Corporation. The company expects to continue its plan to acquire, hold, or spin out successful divisions in what has been described in previous news releases as "dividend farming," Companies that qualify and decide to become public on their own will agree to carve out shares for Tranzbyte and their ERBB shareholders.

Last year, Tranzbyte acquired ProximaRF - a leading-edge company that produces a line of products supporting leading-edge RFID technology.

Tranzbyte also houses the company's 10-year-old technology division which is actively engaged in the sale of its optical media enhancement products to potential customers in the US and Asia. Products in the Tranzbyte division include FLASHAlbum(TM) and FlixStix -- technologies that enable distributors of optical media (CDs, DVDs, etc.) to consolidate the best features of each medium onto a single content-protected USB flash drive.



ProximaRF

ProximaRF was founded in 2006. The company specializes in the development and control of software for Radio Frequency Identification tags called RFIDs. Proxima is currently working on an RFID that can be placed with large legal marijuana shipments so they can be tracked from their grow operation to the dispensaries or other legal sales outlets. This technology should be of invaluable use to both the marijuana seller as well as to law enforcement nationwide


TRANZBYTE CORPORATION
1221 W. Warner Road.,  STE 103
Tempe, Arizona     85284
Main Telephone:     +1 480-443-1600